(PubMed) Eskes TK
Janelle (13:09): So I've done different maintenance doses 0.25 for the semaglutide, which is the lowest starting dose, or I'll do it less frequently
If your goal is cosmetic, our aesthetics team can discuss approaches that do not carry these risks
Based on accumulated evidence, it does not seem like GLP-1 drugs when used during the months after conception increase the risk of common (adverse) outcomes substantially
Before coverage is allowed for certain costly second-step medications, we require that members first try an effective, but less expensive, first-step medication
How the Three Pathways Work Together What makes the design work is that the three receptor pathways complement each other: GLP-1 reduces energy intake (you eat less) GIP optimizes how that energy is used (better insulin sensitivity, favorable fat distribution) Glucagon increases energy expenditure (you burn more calories at rest and mobilize stored fat) The net effect: you eat less, your body uses energy more efficiently, and you burn more calories at rest
